Functional interaction of hepatitis C Virus NS5B with Nucleolin GAR domain. 2007

Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
Division of Signal Transduction, Cancer Research Institute, University Hospital, Kanazawa University, Takara-Machi, Kanazawa, Ishikawa, Japan.

Hepatitis C Virus (HCV) non-structural proteins are major components of replication complex that is modulated by several host factors. We previously reported that nucleolin, a representative nucleolar marker, interacts with the NS5B through two separated sequences, amino acids (aa) 208-214 and 500-506, and that W208 in the former stretch is essential for both nucleolin-binding and HCV replication. Here we evaluated the role of the latter stretch aa 500-506 of WRHRARS in nucleolin-binding and HCV replication scanned by alanine-substituted clustered mutant (cm) or point mutant (pm). One tryptophan and three arginine residues in the sequence were found to be essential both for nucleolin-binding in vivo and HCV replication detected with a HCV subgenomic replicon transfected into Huh7 cells. NS5B-binding of nucleolin was further delineated by truncation and clustered mutants of nucleolin. Arginine-glycine-glycine (RGG) repeat in the Glycine arginine rich (GAR) domain were defined to be indispensable for NS5B-binding immunologically detected in in vivo and in vitro although short internal-truncations of RGG repeat are tolerable for NS5B-binding. These results indicate that nucleolin is a critical host factor for HCV replication through the direct interaction between W208 and several residues at the sequence, aa 500-505, of NS5B, and the long-turn motif including RGG repeat at nucleolin C-terminal.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010750 Phosphoproteins Phosphoprotein
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D000097796 Nucleolin Phosphoprotein found in nucleoli, on the cell membrane, and in cytoplasm of all higher eukaryotes. They act as a receptor for some viruses, bacteria, and toxins. C23 Protein
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
February 2003, The Journal of biological chemistry,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
June 2008, FEBS letters,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
March 2004, Journal of virology,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
November 2003, FEBS letters,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
January 2012, Cellular and molecular life sciences : CMLS,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
July 2004, Nihon rinsho. Japanese journal of clinical medicine,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
January 2006, Bioorganic & medicinal chemistry letters,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
November 2005, Journal of virology,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
January 2021, Frontiers in microbiology,
Takashi Kusakawa, and Tetsuro Shimakami, and Shuichi Kaneko, and Katsuji Yoshioka, and Seishi Murakami
November 2006, Journal of virology,
Copied contents to your clipboard!